Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETON stock hub

Eton Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

811.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ETON

In the news

Latest news · ETON

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37.1

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-18.2

P25 -105.6P50 -46.5P75 -3.1

ROIC20.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001710340
Company name	Eton Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	29772L108
Employees	44
Employees Change	13%
Employees Change Percent	41.94
Enterprise value	$816.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2018-11-13
Isin	US29772L1089
Last refreshed	2026-05-10
Market cap	$811.2M
Market cap category	Small-Cap
Price	$29.65
Price currency	USD
Rev Per Employee	1,817,045.45x
Sector	Healthcare
Sic	2834
Symbol	ETON
Website	https://www.etonpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.57%
EV Sales Forward	7.25x
EV/EBIT	168.98x
EV/EBITDA	91.98x
EV/FCF	80.11x
EV/Sales	10.21x
FCF yield	1.26%
Forward P/E	37.06x
P/B ratio	30.66x
P/S ratio	10.15x
PS Forward	7.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.04%
EBITDA Margin	11.1%
FCF margin	12.75%
Gross margin	59.83%
Gross Profit	$47.8M
Gross Profit Growth	104.32%
Gross Profit Growth Q	124.23%
Gross Profit Growth3 Y	49.49%
Net Income	$-4.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-5.7%
Profit Margin	-5.75%
Profit Per Employee	$-104,568
ROA	3.59
Roa5y	-4.94
ROCE	9.01
ROE	-18.19
Roe5y	-22.88
ROIC	20.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	72.15%
Cagr3y	101.92%
Cagr5y	30.25%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	980.7%
FCF Growth3 Y	28.68%
OCF Growth	986.07%
OCF Growth3 Y	29.72%
Revenue Growth	104.94x
Revenue Growth Q	82.72x
Revenue Growth Quarters	6x
Revenue Growth Years	3x
Revenue Growth3 Y	55.53x
Revenue Growth5 Y	359.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.95
Assets	$92.1M
Cash	$25.9M
Current Assets	$60.6M
Current Liabilities	$38.5M
Debt	$31.1M
Debt EBITDA	$3.47
Debt Equity	$1.19
Debt FCF	$3.05
Equity	$26.2M
Interest Coverage	1.01
Liabilities	$66M
Long Term Assets	$31.5M
Long Term Liabilities	$27.5M
Net Cash	$-5.1M
Net Cash By Market Cap	$-0.63
Net Debt EBITDA	$0.58
Net Debt Equity	$0.2
Net Debt FCF	$0.5
Tangible Book Value	$-4.7M
Tangible Book Value Per Share	$-0.17
WACC	8.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Inventory Turnover	2.1
Net Working Capital	$5M
Quick ratio	0.98
Working Capital	$22.1M
Working Capital Turnover	$3.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	72.08%
200-day SMA	18.62
3Y total return	723.61%
50-day SMA	23.26
50-day SMA vs 200-day SMA	50over200
5Y total return	274.84%
All Time High	32.31
All Time High Change	-8.23%
All Time High Date	2026-05-05
All Time Low	1.95
All Time Low Change	1,420.51%
All Time Low Date	2022-09-23
ATR	1.55
Beta	0.82
Beta1y	0.35
Beta2y	0.76
Ch YTD	75.34
High	30.93
High52	32.31
High52 Date	2026-05-05
High52ch	-8.23%
Low	29.29
Low52	13.09
Low52 Date	2025-06-25
Low52ch	126.6%
Ma50ch	27.5%
Price vs 200-day SMA	59.25%
RSI	65.73
RSI Monthly	71.94
RSI Weekly	74.24
Sharpe ratio	1.17x
Sortino ratio	2.08
Total Return	-3.91%
Tr YTD	75.34
Tr1m	18.32%
Tr1w	2.6%
Tr3m	100.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	3
Analyst Price Target Top	$39.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.13
Earnings EPS Estimate Growth	85.71
Earnings Revenue Estimate	22,394,000x
Earnings Revenue Estimate Growth	29.58x
Operating Income	$4.8M
Operating Income Growth Q	327.8
Operating margin	6.04
Price target	$39.33
Price Target Change	$32.65
Price Target Change Top	$32.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,113,318%
Float Percent	77.17%
Shares Insiders	4.96%
Shares Institutions	40.18%
Shares Out	27,359,791
Shares Qo Q	16.18%
Shares Yo Y	3.91%
Short Float	8.49%
Short Ratio	3.69
Short Shares	6.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.7M
Average Volume	400,896.9x
Bv Per Share	0.97
CAPEX	$-333,000
Ch1m	18.32
Ch1w	2.6
Ch1y	72.08
Ch3m	100.9
Ch3y	723.6
Ch5y	274.8
Ch6m	75.44
Change	-4.42%
Change From Open	-4.14
Close	31.02
Days Gap	-0.29
Depreciation Amortization	4,044,000
Dollar Volume	8,442,037
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$4.8M
EBITDA	$8.9M
EPS	$-0.17
F Score	5
FCF	$10.2M
FCF EV Yield	1.25x
FCF Per Share	$0.37
Financing CF	815,000
Fiscal Year End	December
Founded	2,017
Income Tax	$43,000
Investing CF	-333,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	19.05
Ma150ch	55.68%
Ma20	26.18
Ma20ch	13.25%
Net CF	11,006,000
Next Earnings Date	2026-05-14
Open	30.93
Optionable	Yes
P FCF Ratio	79.6
P OCF Ratio	77.08
Position In Range	21.95
Post Close	29.65
Postmarket Change Percent	-1.95
Postmarket Price	$29.07
Ppne	636,000
Price Date	2026-05-08
Price EBITDA	$91.4
Relative Volume	0.71x
Revenue	79,950,000x
SBC By Revenue	6.89x
Share Based Comp	5,512,000
Tax By Revenue	0.05x
Tr6m	75.44%
Us State	Illinois
Volume	284,723
Z Score	3.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETON pay a dividend?

Capital-return profile for this ticker.

Performance

ETON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETON?

Insider, institutional, and short-interest positioning.

Institutional ownership

+40.2%

Float: +77.2% of shares outstanding

Insider ownership

+5.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.7

Neutral momentum band

Price vs 200-day MA

+59.2%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ETON stock rating?

Eton Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ETON analysis?

The full report lives at /stocks/ETON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ETON?

The latest report frames ETON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ETON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.